Mitochondrial transplantation for the treatment of Alzheimer's disease (review)

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Alzheimer's disease (AD) is the most common form of dementia that primarily affects older adults and most often begins with memory loss followed by progressive impairment of behavioral and cognitive functions. Despite the fact that the main pathological signs of AD are considered to be extracellular deposits of beta-amyloid in the form of amyloid plaques and intracellular accumulation of hyperphosphorylated tau protein in the form of neurofibrillary tangles, recently more and more attention at the cellular and molecular levels has been paid to other important processes accompanying development of the disease. In modern research of neurodegenerative diseases, the role of mitochondria is receiving increasing interest. The mitochondrial cascade hypothesis suggests that mitochondrial dysfunction plays a key role in the progression of these neurodegenerative processes. Recent research shows that cells have the ability to exchange mitochondria among themselves. This process, known as horizontal mitochondrial transfer, allows cells to exchange both healthy and damaged or dysfunctional mitochondria, moving them from one cell to another for further repair or degradation, which raises the possibility of using mitochondrial transplantation as a therapy for neurodegenerative diseases.

In this article, we consider two aspects: horizontal mitochondrial transfer and mitochondrial transplantation. Horizontal mitochondrial transfer opens new horizons in understanding cellular communication and interactions. The methods of horizontal transfer of mitochondria discussed in the article are presented and described in detail. Additionally, we review the relevance and innovative nature of mitochondrial transplantation, a procedure in which healthy mitochondria are transferred to cells or organs with dysfunctional mitochondria. We will discuss various mitochondrial transplantation methods and their potential applications in medicine. The article will provide information on new research and perspectives in the field of mitochondrial biology and therapeutics, expanding the understanding of the function and role of mitochondria in living organisms.

Full Text

Restricted Access

About the authors

D. Y. Zhdanova

Institute of Cell Biophysics, Russian Academy of Sciences – a Separate Division of Federal Research Center «Pushchino Research Center for Biological Studies, Russian Academy of Sciences» (ICB RAS)

Author for correspondence.
Email: ddzhdanova@mail.ru

Ph.D. (Biol.), Research Scientist

Russian Federation, Pushchino

A. V. Chaplygina

Institute of Cell Biophysics, Russian Academy of Sciences – a Separate Division  of Federal Research Center «Pushchino Research Center for Biological Studies, Russian Academy of Sciences» (ICB RAS)

Email: ddzhdanova@mail.ru

Research Scientist

Russian Federation, Pushchino

References

  1. Asher S., Priefer R. Alzheimer's disease failed clinical trials. Life sciences. 2022; 120861.
  2. Elgenaidi I.S., Spiers J.P. Regulation of the phosphoprotein phosphatase 2A system and its modulation during oxidative stress: A potential therapeutic target? Pharmacology & therapeutics. 2019; 198: 68–89.
  3. Swerdlow R.H. The mitochondrial hypothesis: dysfunction, bioenergetic defects, and the metabolic link to Alzheimer's disease. International review of neurobiology. 2020; 154: 207–233.
  4. Lin M.T., Beal M.F. Mitochondrial dysfunction and oxida-tive stress in neurodegenerative diseases. Nature. 2006; 443: 787–795.
  5. Zorova L.D., Popkov V.A., Plotnikov E.Y., et al. Mitochondrial membrane potential. Analytical biochemistry. 2018; 552: 50–59.
  6. Mahrouf-Yorgov M., Augeul L., Da Silva C.C., et al. Mesenchymal stem cells sense mitochondria released from damaged cells as danger signals to activate their rescue properties. Cell Death & Differentiation. 2017; 24: 1224–1238.
  7. Wang W., Zhao F., Ma X., et al. Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: Recent advances. Molecular Neurodegeneration. 2020; 15: 1–22.
  8. Iturria-Medina Y., Carbonell F.M., Sotero R.C., et al. Multifactorial causal model of brain (dis) organization and therapeutic intervention: Application to Alzheimer’s disease. Neuroimage. 2017; 152: 60–77.
  9. Hirai K., Aliev G., Nunomura A., et al. Mitochondrial abnormalities in Alzheimer's disease. Journal of Neuroscience. 2001; 21: 3017–3023.
  10. Chang C.Y., Liang M.Z., Chen L. Current progress of mitochondrial transplantation that promotes neuronal regeneration. Translational neurodegeneration. 2019; 8: 1–12.
  11. Swerdlow R.H., Khan S.M. A “mitochondrial cascade hypothesis” for sporadic Alzheimer's disease. Medical hypotheses. 2004; 63: 8–20.
  12. Swerdlow R.H., Burns J.M., Khan S.M. The Alzheimer's disease mitochondrial cascade hypothesis. Journal of Alzheimer's Disease. 2010; 20: S265–S279.
  13. Müller W.E. Eckert A., Eckert G.P., et al. Therapeutic efficacy of the Ginkgo special extract EGb761® within the framework of the mitochondrial cascade hypothesis of Alzheimer’s disease. The World Journal of Biological Psychiatry. 2019; 20: 173–189.
  14. Cardoso S.M., Santos S., Swerdlow R.H., et al. Functional mitochondria are required for amyloid β‐mediated neurotoxicity. The FASEB Journal. 2001; 15: 1439–1441.
  15. Reddy P.H. Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease. Experimental neurology. 2009; 218: 286–292.
  16. Zhang X.D., Wang Y., Wu J.C., et al. Down‐regulation of Bcl‐2 enhances autophagy activation and cell death induced by mitochondrial dysfunction in rat striatum. Journal of neuroscience research. 2009; 87: 3600–3610.
  17. Misrani A., Tabassum S., Yang L. Mitochondrial dysfunction and oxidative stress in Alzheimer’s disease. Frontiers in aging neuroscience. 2021; 13: 57.
  18. Kumagai H., Miller B., Kim S. J., et al. Novel Insights into Mitochondrial DNA: Mitochondrial Microproteins and mtDNA Variants Modulate Athletic Performance and Age-Related Diseases. Genes. 2023; 14: 286.
  19. Mishra M., Raik S., Rattan V., et al. Mitochondria transfer as a potential therapeutic mechanism in Alzheimer’s disease-like pathology. Brain Research. 2023; 1819: 148544.
  20. Hosseinian S., Pour P.A., Kheradvar A. Prospects of mitochondrial transplantation in clinical medicine: Aspirations and challenges. Mitochondrion. 2022; 65: 33–44.
  21. Berridge M.V., McConnell M.J., Grasso C., et al. Horizontal transfer of mitochondria between mammalian cells: beyond co-culture approaches. Current opinion in genetics & development. 2016; 38: 75–82.
  22. Spees J.L., Olson S.D., Whitney M.J., et al. Mitochondrial transfer between cells can rescue aerobic respiration. Proceedings of the National Academy of Sciences. 2006; 103: 1283–1288.
  23. Hayashida K., Takegawa R., Endo Y., et al. Exogenous mitochondrial transplantation improves survival and neurological outcomes after resuscitation from cardiac arrest. BMC medicine. 2023; 21: 56.
  24. Babenko V.A., Silachev D.N., Popkov V.A., et al. Miro1 enhances mitochondria transfer from multipotent mesenchymal stem cells (MMSC) to neural cells and improves the efficacy of cell recovery Molecules. 2018; 23: 687.
  25. Alexander J.F., Seua A.V., Arroyo L.D., et al. Nasal administration of mitochondria reverses chemotherapy-induced cognitive deficits Theranostics. 2021; 11: 3109.
  26. Picone P., Nuzzo D. Promising treatment for multiple sclerosis: mitochondrial transplantation. International Journal of Molecular Sciences. 2022; 23: 2245.
  27. Cowan D.B., Yao R., Thedsanamoorthy J.K., et al. Transit and integration of extracellular mitochondria in human heart cells. Scientific reports. 2017; 7: 17450.
  28. Soundara Rajan T., Gugliandolo A., Bramanti P., et al. Tunneling nanotubes-mediated protection of mesenchymal stem cells: an update from preclinical studies. International Journal of Molecular Sciences. 2020; 21: 3481.
  29. Lin H.Y., Liou C.W., Chen S.D., et al. Mitochondrial transfer from Wharton's jelly-derived mesenchymal stem cells to mitochondria-defective cells recaptures impaired mitochondrial function. Mitochondrion. 2015; 22: 31–44.
  30. John A., Reddy P.H. Synaptic basis of Alzheimer’s disease: Focus on synaptic amyloid beta, P-tau and mitochondria. Ageing research reviews. 2021; 65: 101208
  31. Lampinen R., Belaya I., Saveleva L., et al. Neuron-astrocyte transmitophagy is altered in Alzheimer's disease. Neurobiology of Disease. 2022; 170: 105753.
  32. Pickford F., Masliah E., Britschgi M., et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid β accumulation in mice. The Journal of clinical investigation. 2008; 118: 2190–2199.
  33. Davis C.O., Kim K.-Y., Bushong E.A., et al. Transcellular degradation of axonal mitochondria. Proceedings of the National Academy of Sciences. 2014; 111: 9633–9638.
  34. Hayakawa K., Esposito E., Wang X., et al. Transfer of mitochondria from astrocytes to neurons after stroke. Nature. 2016; 535: 551–555.
  35. Morales I., Sanchez A., Puertas-Avendano R., et al. Neuroglial transmitophagy and Parkinson's disease. Glia. 2020; 68: 2277–2299.
  36. Clemente-Suárez V.J., Martín-Rodríguez A., Yáñez-Sepúlveda R., et al. Mitochondrial Transfer as a Novel Therapeutic Approach in Disease Diagnosis and Treatment. International Journal of Molecular Sciences. 2023; 24: 8848.
  37. Eugenin E., Camporesi E., Peracchia C. Direct cell-cell communication via membrane pores, gap junction channels, and tunneling nanotubes: medical relevance of mitochondrial exchange International journal of molecular sciences. 2022; 23: 6133.
  38. Yang J., Liu, L., Oda, Y., et al. Extracellular Vesicles and Cx43-Gap Junction Channels Are the Main Routes for Mitochondrial Transfer from Ultra-Purified Mesenchymal Stem Cells, RECs. International Journal of Molecular Sciences. 2023; 24: 10294.
  39. Rustom A., Saffrich R., Markovic I., et al. Nanotubular highways for intercellular organelle transport. Science. 2004; 303: 1007–1010
  40. Koyanagi M., Brandes R.P., Haendeler J., et al. Cell-to-cell connection of endothelial progenitor cells with cardiac myocytes by nanotubes: a novel mechanism for cell fate changes? Circulation research. 2005; 96: 1039–1041.
  41. Driscoll J., Gondaliya P., Patel T. Tunneling nanotube-mediated communication: a mechanism of intercellular nucleic acid transfer. International journal of molecular sciences. 2022; 23: 5487.
  42. Kloc M., Uosef A., Wosik J., et al. Virus interactions with the actin cytoskeleton—what we know and do not know about SARS-CoV-2. Archives of virology. 2022; 167: 737–749.
  43. Vignais M. L., Caicedo A., Brondello J.M., et al. Cell connections by tunneling nanotubes: effects of mitochondrial trafficking on target cell metabolism, homeostasis, and response to therapy. Stem cells international. 2017; 2017: 6917941.
  44. Ahmad T., Mukherjee S., Pattnaik B., et al. Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efficacy. The EMBO journal. 2014; 33: 994–1010.
  45. Sun X., Wang Y., Zhang J., et al. Tunneling-nanotube direction determination in neurons and astrocytes. Cell death & disease. 2012; 3: e438–e438.
  46. Zheng F., Luo Z., Lin X., et al. Intercellular transfer of mitochondria via tunneling nanotubes protects against cobalt nanoparticle-induced neurotoxicity and mitochondrial damage. Nanotoxicology. 2021; 15: 1358–1379.
  47. D’Amato M., Morra F., Di Meo I., et al. Mitochondrial transplantation in mitochondrial medicine: current challenges and future perspectives. International journal of molecular sciences. 2023; 24: 1969.
  48. van Niel G., Carter D.R., Clayton A., et al. Challenges and directions in studying cell–cell communication by extracellular vesicles. Nature Reviews Molecular Cell Biology. 2022; 23: 369–382.
  49. Cheng L., Hill A.F. Therapeutically harnessing extracellular vesicles. Nature Reviews Drug Discovery. 2022; 21: 379–399.
  50. Jeppesen D. K., Zhang Q., Franklin J.L., et al. Extracellular vesicles and nanoparticles: Emerging complexities. Trends in Cell Biology. 2023; 33: 667–681.
  51. Peruzzotti-Jametti L., Bernstock J.D., Willis C.M., et al. Neural stem cells traffic functional mitochondria via extracellular vesicles. PLoS biology. 2021; 19: e3001166.
  52. Zhang T., Miao C. Mitochondrial transplantation as a promising therapy for mitochondrial diseases. Acta Pharmaceutica Sinica B. 2023; 13: 1028–1035.
  53. Sheehan J.P., Swerdlow R.H., Miller S.W., et al. Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer’s disease. Journal of Neuroscience. 1997; 17: 4612–4622.
  54. Nitzan K., Benhamron S., Valitsky M., et al. Mitochondrial transfer ameliorates cognitive deficits, neuronal loss, and gliosis in Alzheimer’s disease mice. Journal of Alzheimer's Disease. 2019; 72: 587–604.
  55. Ma H., Jiang T., Tang W., et al. Transplantation of platelet-derived mitochondria alleviates cognitive impairment and mitochondrial dysfunction in db/db mice. Clinical Science. 2020; 134: 2161–2175.
  56. Adlimoghaddam A., Benson T., Albensi B.C. Mitochondrial transfusion improves mitochondrial function through up-regulation of mitochondrial complex II protein subunit SDHB in the Hippocampus of aged mice. Molecular Neurobiology. 2022; 59: 6009–6017.
  57. Zhang Z., Sheng H., Liao L.I., et al. Mesenchymal stem cell-conditioned medium improves mitochondrial dysfunction and suppresses apoptosis in okadaic acid-treated SH-SY5Y cells by extracellular vesicle mitochondrial transfer. Journal of Alzheimer's Disease. 2020; 78: 1161–1176.
  58. Bertero E., O’Rourke B., Maack C. Mitochondria do not survive calcium overload during transplantation. Circulation research. 2020; 126: 784–786.
  59. McCully J.D., Emani S.M., Del Nido P.J. Letter by McCully et al Regarding Article,"Mitochondria do not survive calcium overload". Circulation research. 2020; 126: e56–e57.
  60. Bobkova N.V., Zhdanova D.Y., Belosludtseva N.V., et al. Intranasal administration of mitochondria improves spatial memory in olfactory bulbectomized mice. Experimental Biology and Medicine. 2022; 247: 416–425.
  61. Park A., Oh M., Lee S.J., et al. Mitochondrial transplantation as a novel therapeutic strategy for mitochondrial diseases. International journal of molecular sciences. 2021; 22: 4793.
  62. Pacak C.A., Preble J.M., Kondo H., et al. Actin-dependent mitochondrial internalization in cardiomyocytes: evidence for rescue of mitochondrial function. Biology open. 2015; 4: 622–626.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2023 Zhdanova D.Y., Chaplygina A.V.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies